Anesth Pain Med.  2018 Oct;13(4):419-422. 10.17085/apm.2018.13.4.419.

Anesthetic management of a chronic liver disease patient with very low platelet counts by considering a rebalanced hemostasis: A case report

Affiliations
  • 1Department of Anesthesiology and Pain Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea. gskim@skku.edu

Abstract

The coagulation profile of patients with end-stage liver disease (ESLD) is different from that of healthy individuals. Because hemostasis is rebalanced in chronic liver disease, prophylactic transfusion of blood products may be not necessary for these patients even if they show severe coagulation dysfunction in conventional coagulation results. A 44-year-old man with hepatocellular carcinoma, cholangiocarcinoma and liver cirrhosis was scheduled for extra-hepatic mass excision under general anesthesia. His preoperative tests showed severe thrombocytopenia 19 × 10⁹/L. The patient underwent extrahepatic mass excision surgery under general anesthesia without transfusion of blood products. The post-operative course was uneventful without requiring any further hemostatic therapy. In this case report, we focus on the concept of rebalanced hemostasis in ESLD, and coagulation management based on rotational thromboelastometry.

Keyword

Blood coagulation; Blood platelets; Rebalanced hemostasis; Rotational thromboelastometry; Thromboelastography

MeSH Terms

Adult
Anesthesia, General
Blood Coagulation
Blood Platelets*
Carcinoma, Hepatocellular
Cholangiocarcinoma
Hemostasis*
Humans
Liver Cirrhosis
Liver Diseases*
Liver*
Platelet Count*
Thrombelastography
Thrombocytopenia

Figure

  • Fig. 1 Computed tomography (CT) of the the extrahepatic mass. CT shows a slight increase in the size (2.8 cm) of the presumed seeding nodule in the peri-hepatic space, adjacent to liver segment 6 with splenomegaly.

  • Fig. 2 Variation in the platelet counts after transfusion of single donor platelets (SDP). OP: operation, POD: postoperative day. *Platelet counts after 2 units of SDP transfusion. †Platelet counts after 3 units of SDP transfusion.


Reference

REFERENCE

1. Shah NL, Northup PG, Caldwell SH. A clinical survey of bleeding, thrombosis, and blood product use in decompensated cirrhosis patients. Ann Hepatol. 2012; 11:686–90. PMID: 22947530.
2. Shah NL, Caldwell SH. Assessing the risk of bleeding and clotting in cirrhosis. Clin Liver Dis. 2016; 7:26–8. DOI: 10.1002/cld.528.
3. Lisman T, Porte RJ. Rebalanced hemostasis in patients with liver disease:evidence and clinical consequences. Blood. 2010; 116:878–85. DOI: 10.1182/blood-2010-02-261891. PMID: 20400681.
4. Henry Z, Northup PG. The rebalanced hemostasis system in end-stage liver disease and its impact on liver transplantation. Int Anesthesiol Clin. 2017; 55:107–20. DOI: 10.1097/AIA.0000000000000139. PMID: 28221169.
5. Lisman T, Leebeek FW, Mosnier LO, Bouma BN, Meijers JC, Janssen HL, et al. Thrombin-activatable fibrinolysis inhibitor deficiency in cirrhosis is not associated with increased plasma fibrinolysis. Gastroenterology. 2001; 121:131–9. DOI: 10.1053/gast.2001.25481. PMID: 11438502.
6. Weeder PD, Porte RJ, Lisman T. Hemostasis in liver disease:implications of new concepts for perioperative management. Transfus Med Rev. 2014; 28:107–13. DOI: 10.1016/j.tmrv.2014.03.002. PMID: 24721432.
7. Ganter MT, Hofer CK. Coagulation monitoring:current techniques and clinical use of viscoelastic point-of-care coagulation devices. Anesth Analg. 2008; 106:1366–75. DOI: 10.1213/ane.0b013e318168b367. PMID: 18420846.
8. Hartmann M, Szalai C, Saner FH. Hemostasis in liver transplantation:pathophysiology, monitoring, and treatment. World J Gastroenterol. 2016; 22:1541–50. DOI: 10.3748/wjg.v22.i4.1541. PMID: 26819521. PMCID: PMC4721987.
9. Kim TY. Perioperative bleeding disorder and intraoperative ponit-of-care testing of coagulation during cardiac surgery. Anesth Pain Med. 2011; 6:1–15.
10. Kaufman RM, Djulbegovic B, Gernsheimer T, Kleinman S, Tinmouth AT, Capocelli KE, et al. Platelet transfusion:a clinical practice guideline from the AABB. Ann Intern Med. 2015; 162:205–13. DOI: 10.7326/M14-1589. PMID: 25383671.
Full Text Links
  • APM
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr